The PD-1 and PD-L1 signal pathway plays a critical role in modulating activation of T lymphocytes and the pathway blockade has elicited durable antitumor responses and long-term remissions in a subset of patients with a broad spectrum of cancer. The gene discussed is CD274; the disease is cancer.